APA (7th ed.) Citation

Tomelleri, A., Bond, M., Marvisi, C., Campochiaro, C., Farina, N., Venerandi, B., . . . Dagna, L. (2025). Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure. Rheumatology, 64(9), 5118. https://doi.org/10.1093/rheumatology/keaf250

Chicago Style (17th ed.) Citation

Tomelleri, Alessandro, et al. "Secukinumab Is Effective and Safe for Patients with Giant Cell Arteritis After Tocilizumab Failure." Rheumatology 64, no. 9 (2025): 5118. https://doi.org/10.1093/rheumatology/keaf250.

MLA (9th ed.) Citation

Tomelleri, Alessandro, et al. "Secukinumab Is Effective and Safe for Patients with Giant Cell Arteritis After Tocilizumab Failure." Rheumatology, vol. 64, no. 9, 2025, p. 5118, https://doi.org/10.1093/rheumatology/keaf250.